<![CDATA[CIP-Net Podcast]]>The CIP-Net Podcast, from the NCI Cancer Immunoprevention Network (CIP-Net), explores the emerging science of cancer immunoprevention and immunointerception through engaging conversations with researchers, clinicians, and patient advocates. The series highlights advances in the field while connecting scientific discovery with patient and community perspectives.

]]>www.nci-cipnet.orgRiverside.fm (https://riverside.com)Fri, 11 Sep 2026 03:12:34 GMTWed, 02 Sep 2026 16:39:40 GMT60CIP-Net Data and Resource Coordinating Center<p>The <b>CIP-Net Podcast</b>, from the <b>NCI Cancer Immunoprevention Network (CIP-Net)</b>, explores the emerging science of cancer immunoprevention and immunointerception through engaging conversations with researchers, clinicians, and patient advocates. The series highlights advances in the field while connecting scientific discovery with patient and community perspectives.</p>episodicCIP-Net Data and Resource Coordinating Centervero.zhang@gmail.comno<![CDATA[What Is Cancer Immunoprevention? A Conversation on Preventing Cancer Before It Starts]]>Featuring

Bodour Salhia, PhD
Professor, University of Southern California
Dr. Salhia is a cancer researcher and patient advocate whose perspective bridges scientific research and lived experience as a cancer survivor.

Robert Samstein, MD, PhD
Associate Professor, Icahn School of Medicine at Mount Sinai

Dr. Samstein is a radiation oncologist and physician-scientist whose research explores how the immune system recognizes and eliminates abnormal cells before cancer develops. He co-leads a CIP-Net research center studying Lynch syndrome and the immune mechanisms that may inform new cancer immunoprevention strategies.

Episode Summary

What if we could harness the immune system to stop cancer before it starts?

In the inaugural episode of the CIP-Net Podcast, Drs. Bodour Salhia and Robert Samstein explore the emerging field of cancer immunoprevention—using the immune system to recognize and eliminate cancer at its earliest stages. They discuss why prevention may offer unique advantages over treating established cancer, who may benefit most from immunoprevention strategies, and the opportunities and challenges of translating this science into clinical practice.

The conversation also examines the importance of patient perspectives, long-term NCI support, and collaboration through CIP-Net in moving cancer prevention research forward—from understanding early cancer development to ultimately intercepting cancer before it becomes clinically detectable.

Takeaways

  • Cancer immunoprevention is an emerging and exciting frontier in cancer research.
  • Collaboration through CIP-Net is crucial for accelerating discoveries in cancer prevention. Immunoprevention aims to use the immune system to prevent cancer before it develops.
  • Early cancer stages may occur at a very early age, providing an opportunity for intervention.
  • Prevention is important for reducing cancer burden and improving patient outcomes.

Chapters

  • 00:00 Introduction to Cancer Immunoprevention
  • 21:41 The Role of CIP-Net in Cancer Prevention
  • 23:30 Understanding Immunoprevention
  • 24:05 Immunoprevention: Harnessing the Immune System
  • 26:34 Understanding Cancer Development
  • 28:12 The Importance of Prevention
  • 41:39 Challenges in Prevention Research
  • 44:52 CIP-Net: Cancer Immunoprevention Network
  • 53:57 The Future of Cancer Immunoprevention
]]>b67c5d11-9bd8-4583-88a0-62437dd9b727Wed, 02 Sep 2026 18:02:25 GMT<p><b>Featuring</b></p><p><b>Bodour Salhia, PhD</b><br /><i>Professor, University of Southern California</i><br />Dr. Salhia is a cancer researcher and patient advocate whose perspective bridges scientific research and lived experience as a cancer survivor.</p><p></p><p><b>Robert Samstein, MD, PhD</b><br /><i>Associate Professor, Icahn School of Medicine at Mount Sinai</i></p><p>Dr. Samstein is a radiation oncologist and physician-scientist whose research explores how the immune system recognizes and eliminates abnormal cells before cancer develops. He co-leads a CIP-Net research center studying Lynch syndrome and the immune mechanisms that may inform new cancer immunoprevention strategies.</p><p></p><p><b>Episode Summary</b></p><p>What if we could harness the immune system to stop cancer before it starts?</p><p>In the inaugural episode of the CIP-Net Podcast, Drs. Bodour Salhia and Robert Samstein explore the emerging field of <b>cancer immunoprevention</b>—using the immune system to recognize and eliminate cancer at its earliest stages. They discuss why prevention may offer unique advantages over treating established cancer, who may benefit most from immunoprevention strategies, and the opportunities and challenges of translating this science into clinical practice.</p><p>The conversation also examines the importance of patient perspectives, long-term NCI support, and collaboration through CIP-Net in moving cancer prevention research forward—from understanding early cancer development to ultimately intercepting cancer before it becomes clinically detectable.</p><p></p><p><b>Takeaways</b></p><ul><li>Cancer immunoprevention is an emerging and exciting frontier in cancer research.</li><li>Collaboration through CIP-Net is crucial for accelerating discoveries in cancer prevention. Immunoprevention aims to use the immune system to prevent cancer before it develops.</li><li>Early cancer stages may occur at a very early age, providing an opportunity for intervention.</li><li>Prevention is important for reducing cancer burden and improving patient outcomes.</li></ul><p></p><p><b>Chapters</b></p><ul><li>00:00 Introduction to Cancer Immunoprevention</li><li>21:41 The Role of CIP-Net in Cancer Prevention</li><li>23:30 Understanding Immunoprevention</li><li>24:05 Immunoprevention: Harnessing the Immune System</li><li>26:34 Understanding Cancer Development</li><li>28:12 The Importance of Prevention</li><li>41:39 Challenges in Prevention Research</li><li>44:52 CIP-Net: Cancer Immunoprevention Network</li><li>53:57 The Future of Cancer Immunoprevention</li></ul>no00:29:5411What Is Cancer Immunoprevention? A Conversation on Preventing Cancer Before It Startsfull